Induction of Labor using Misoprostol in a Tertiary Hospital in the Southeast of Brazil

Página do item simplificado
dc.citation.issue10
dc.citation.volume39
dc.contributor.authorGodoy Silva, Tacito Augusto
dc.contributor.authorBorges Junior, Luciano Eliziario
dc.contributor.authorTahan, Luisa Almeida
dc.contributor.authorArantes Costa, Taynna Ferreira
dc.contributor.authorMagalhaes, Fernanda Oliveira
dc.contributor.authorPeixoto, Alberto Borges
dc.contributor.authorMartins, Wellington de Paula
dc.contributor.authorAraujo Junior, Edward [UNIFESP]
dc.coverageRio De Janeiro Rj
dc.date.accessioned2020-08-04T13:39:56Z
dc.date.available2020-08-04T13:39:56Z
dc.date.issued2017
dc.description.abstractPurpose To assess cases of labor induction with vaginal 25-mu g tablets of misoprostol and maternal outcomes in a tertiary hospital in southeastern Brazil. Methods This was a retrospective cohort study of 412 pregnant women with indication for labor induction. Labor induction was performed with vaginal 25-mu g tablets ofmisoprostol in pregnant women with Bishop scores < 6. Stepwise regression analysis was used to identify the factors present at the beginning of induction that could be used as predictors of successful labor induction. Results A total of 69% of the pregnant women who underwent labor induction progressed to vaginal delivery, and 31% of the women progressed to cesarean section. One or two misoprostol tablets were used in 244 patients (59.2%). Of the 412 patients, 197 (47.8%) required oxytocin later on in the labor process, after induction with misoprostol. The stepwise regression analysis showed that only Bishop scores of 4 and 5 and previous vaginal delivery were independent factors with statistical significance in the prediction of successful vaginal labor induction (beta = 0.23, p < 0.001, for a Bishop score of 4 and 5, and beta = 0.22, p < 0.001, for previous vaginal delivery). Conclusion Higher Bishop scores and previous vaginal delivery were the best predictors of successful labor induction with vaginal 25-mu g tablets of misoprostol.en
dc.description.affiliationUniv Uberaba UNIUBE, Mario Palmerio Hosp Univ, Uberaba, MG, Brazil
dc.description.affiliationUniv Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, SP, Brazil
dc.description.affiliationUniv Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Obstet, Sao Paulo, SP, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Obstet, Sao Paulo, SP, Brazil
dc.description.sourceWeb of Science
dc.format.extent523-528
dc.identifierhttp://dx.doi.org/10.1055/s-0037-1604259
dc.identifier.citationRevista Brasileira De Ginecologia E Obstetricia. Rio De Janeiro Rj, v. 39, n. 10, p. 523-528, 2017.
dc.identifier.doi10.1055/s-0037-1604259
dc.identifier.issn0100-7203
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/57186
dc.identifier.wosWOS:000418071000002
dc.language.isoeng
dc.publisherFederacao Brasileira Soc Ginecologia & Obstetricia-Febrasgo
dc.relation.ispartofRevista Brasileira De Ginecologia E Obstetricia
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectlabor inductionen
dc.subjectmisoprostolen
dc.subjectoxytocinen
dc.subjectcesarean sectionsen
dc.titleInduction of Labor using Misoprostol in a Tertiary Hospital in the Southeast of Brazilen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos